Mounjaro and Anxiety: What Patients Actually Experience

Anxiety is not among the common or very common side effects of tirzepatide listed in the UK SmPC — but it has been reported by some patients.
Low blood sugar (hypoglycaemia), rapid weight loss, changes in appetite and disrupted sleep can all produce anxiety-like symptoms that may be mistaken for a direct drug effect.
The MHRA's Yellow Card scheme allows anyone to report a suspected side effect, including mood changes, at yellowcard.mhra.gov.uk.
Any new or worsening anxiety, low mood or changes in mental health while on Mounjaro should be discussed with your prescriber promptly.

Anxiety is not listed as a common side effect of Mounjaro (tirzepatide) in the UK prescribing information, but some people do report feeling anxious or on edge after starting treatment. Understanding why that happens, and when it matters, is the most useful thing you can do. Mounjaro is a prescription-only medicine requiring clinical assessment before anyone can be prescribed it.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

What the evidence says about Mounjaro, anxiety and mood changes — step by step

Step 1: Check whether anxiety appears in the official side-effect profile

When patients search for information on Mounjaro's side effects, anxiety tends to be high on their list, partly because online forums amplify individual experiences. The factual starting point is the UK Summary of Product Characteristics (SmPC) for tirzepatide, held on the Electronic Medicines Compendium. The very common and common side effects listed there are overwhelmingly gastrointestinal: nausea, diarrhoea, vomiting, constipation, indigestion. Dizziness, fatigue and headache also feature. Anxiety does not appear in those tiers.

That does not mean it cannot happen. The SmPC also records uncommon and rare events where the evidence base is thinner, and post-marketing reports can surface effects that larger trials did not capture at a statistically significant rate. The NHS medicines page for tirzepatide gives a plain-English summary of the same risk hierarchy. Anyone wondering specifically whether Mounjaro can cause anxiety will find a detailed evidence-based answer on that page before drawing conclusions. If anxiety still doesn't explain what you are feeling, the next step is working out which indirect mechanism might.

Step 2: Rule out the more common indirect causes

Several things that tirzepatide does to the body can produce anxiety-like sensations without acting directly on mood pathways. Recognising them is genuinely useful.

Blood sugar fluctuations. Mounjaro slows gastric emptying and dampens appetite. If someone eats significantly less than usual, particularly skipping carbohydrates, blood glucose can drop lower than the body is used to. The classic response to a blood-sugar dip (shakiness, a racing heart, a sense of unease) feels a great deal like anxiety. Keeping the tablet or pen record next to your diary (or, practically, your pen in the fridge door you open most mornings) makes it easier to connect symptoms to dose timing.

Caffeine sensitivity. Slower gastric emptying means coffee and other stimulants are absorbed differently. The same cup that felt fine before treatment can hit harder, and the physical effects of extra caffeine (elevated heart rate, jitteriness) are hard to distinguish from anxious feelings.

Rapid early weight loss. Significant calorie restriction and weight change affect hormones, sleep quality and energy. Poor sleep, which is common during the early weeks of any major dietary change, is itself a reliable driver of next-day anxiety.

The question of why Mounjaro can cause anxiety in some individuals is explored in more depth on a dedicated page if you want the mechanistic detail.

Step 3: Know when to contact your prescriber

Mild unease in the first week or two after a dose increase is not unusual, most people's bodies settle. Anxiety that persists beyond two weeks, feels severe, or arrives alongside low mood or thoughts of self-harm is a different matter entirely. Contact your prescriber the same day if that is what you are experiencing. Worsening anxiety on Mounjaro should always be assessed clinically rather than managed by self-adjusting your dose.

A few other signals worth acting on promptly: palpitations that are sustained rather than brief, chest tightness, or a feeling that something is physically wrong rather than emotionally unsettled. These can overlap with anxiety but may point to something else. The MHRA asks patients to report any suspected side effects (including psychological ones) through the Yellow Card scheme; reports from real-world patients help regulators track emerging signals before they reach the prescribing information.

It is also worth knowing that pre-existing anxiety disorders do not automatically rule someone out from tirzepatide, but they do need to be part of the clinical conversation. A prescriber who knows your full history can weigh the benefit against any additional monitoring you might need. For context on how treatment cost fits into broader planning, the Mounjaro cost page covers what private prescriptions typically include.

Step 4: What to tell your prescriber, and what they may consider

The more specific you can be, the easier it is for a clinician to help. Useful things to note: when the anxious feelings start relative to your weekly injection (or daily tablet if you are on a different preparation), whether they coincide with meals or fasting periods, how your sleep has been, and whether caffeine or alcohol intake has changed. That pattern tells a different story from anxiety that sits at a constant background level regardless of timing.

Your prescriber may consider whether a slower dose titration would allow your system more time to adjust, or whether something in your lifestyle during the early weeks is amplifying the effect. They will not simply tell you to stop; anxiety as a reported side effect has a range of management options depending on the cause. The clinical team at nume reviews every patient's progress before each repeat prescription, which means concerns raised between orders are taken into account for the next clinical decision, not stored away. If you have questions now, our support team is available seven days a week.

If you are considering starting tirzepatide and want to discuss how it might interact with an existing anxiety condition, speaking to our prescribers is the right place to begin.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions